Back to Noidecs or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Strain Estimate)

MyrceneMajorHerbal/Musk166-168℃
OcimeneMajorHerbal/Sweet174-175℃
TerpinoleneMajorFloral/Herbal185℃

MedBud currently tracks 16 common terpenes, more will be added.

No full terpene profile has been provided for this product, information above may be estimated based on public strain information.

Dosing Look-Up Table (Estimated)

0.01/g2/mg THC0.4/mg CBD
0.05/g10/mg THC2/mg CBD
0.1/g20/mg THC4/mg CBD
0.15/g30/mg THC6/mg CBD
0.2/g40/mg THC8/mg CBD
0.25/g50/mg THC10/mg CBD
0.3/g60/mg THC12/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
United Kingdom Noidecs
Designation
T20:C4
Cultivar/Strain
Moby Dick
Classification
Sativa Hybrid
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
18-22%
CBD Potential Range (±10%)
4%
Cultivated/Produced by
Israel BOL Pharma
Cultivated or Packaged in
Flag of Israel Israel
Irradiation
Gamma-Irradiated
Imported by
United Kingdom Eaststone
Imported as
Schedule II: Finished Product

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Discontinued

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Product Description Video Reviews1 Patient Reviews

About Moby Dick

MDSativa Hybrid

Moby Dick is designed specifically as a strong medical strain. It is excellent for daytime use though patients may feel lazy a few hours after use.

Dutch Flag Dutch Bred

Moby Dick is a Sativa-dominant strain. Its name reflects its massive yields, which reportedly can reach 1,500 grams per square meter. The THC concentration of this strain may be as high as 20%.

The effects of this strain are highly psychoactive, due to a high count of tetrahydrocannabivarin (THCV). It produces strong euphoria and gives spacey, happy, and slightly psychedelic sensations after only one or two hits. Some users feel creative and focused. The strong cerebral effects begin to diminish after about an hour, but the residual effects can last another two hours. These effects are coupled with pleasant body numbing sensations. Strong and trippy, this strain induces an insatiable appetite. This mega-strain may result in dry eyes and mouth and lead to paranoia, dizziness, and anxiety when consumed in high doses.

Moby Dick is designed specifically as a strong medical strain. It is excellent for daytime use though patients may feel lazy a few hours after use. The cerebral effects are often used to combat the symptoms of stress, anxiety, and depression. Patients that have lost their appetites, whether it's due to chemotherapy or other reasons, often choose this strain. The body high may ease mild aches and pains, but it is not strong enough to combat severe pain.

Moby Dick comes from the breeders at Dinafem (dinafem.org) who crossed two of their mother plants, a variety of Haze and a variety of White Widow. The strain has two phenotypes: one with Sativa-dominant characteristics that can reach up to twelve feet outdoors, while the other is a smaller, Indica-dominant phenotype, that is only seen about 35% of the time.

Description provided by Wikileaf.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

United Kingdom About Lyphe Group Ltd

Noidecs Logo

From Lyphe Group, a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.

At Lyphe our vertical operations span product manufacturing, clinical care, pharmacy dispensing and doctor education. Our direct-to-patient and technology-led approach has quickly established us as the market’s largest player, with a 30% share of all patients. We have also recently entered the Australian market, where we intend to replicate our model of success.

lyphegroup.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)